Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Stay updated with breaking news from Bennett Watson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
(PRINCETON, NJ) -- McCarter Theatre Center opens their 2023-2024 Theatre Series with Eisa Davis' Bulrusher, a transformational coming-of-age story filled to the brim with passion, humor, and even a touch of magic; on stage in the Berlind Theatre from September 13 – October 7, 2023. This is a co-production with Berkeley Repertory Theatre, where the production will move after its run in Princeton.
Operator: Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode.
AQST earnings call for the period ending June 30, 2022.
AQST earnings call for the period ending March 31, 2022.